Aubagio ‘slows brain atrophy in RRMS patients’
Aubagio ‘slows brain atrophy in RRMS patients’
Genzyme has announced results from magnetic resonance imaging (MRI) analysis of participants in the Phase III TEMSO clinical trial showing Aubagio was able to slow the loss of brain volume (or atrophy) versus a placebo over two years in patients with relapsing-remitting multiple sclerosis (RRMS)... Read More - http://www.ms-uk.org/MSnews
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 12654 Views
-
Last post by accordingnature495
-
- 0 Replies
- 1925 Views
-
Last post by NHE
-
- 0 Replies
- 1635 Views
-
Last post by NHE
-
- 4 Replies
- 1569 Views
-
Last post by NHE
-
- 0 Replies
- 1263 Views
-
Last post by NHE
-
- 0 Replies
- 1613 Views
-
Last post by NHE
-
- 0 Replies
- 2068 Views
-
Last post by frodo
-
- 0 Replies
- 2171 Views
-
Last post by NHE
-
- 0 Replies
- 1733 Views
-
Last post by NHE